Drugs / Sofosbuvir/Ledipasvir
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02503735 | Jul 2015 → Sep 2017 | chronic kidney disease, hepatitis C virus infection | Massachusetts General Hospital | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sofosbuvir/Ledipasvir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02503735 ↗ |